Prevalence of Covishield COVID-19 Vaccine (ChAdOx1 nCoV-19) Adverse Effects among Health Care Workers in Sri Lanka

Manilgama, Suranga; Hettiarachchi, Nalin; Jayasinghe, Krishani; Silva, S. De; Wanigaratne, Thushari; Jayalath, Thilak; Bandusiri, R.P.; Suganthan, Navaneethakrishnan; Sudarshan, P.; Pathirage, Manoji; Rajaratnam, N.; Senaratne, Ganaka; Rajapaksha, V.; Wickramasinghe, Anura; Kulaweera, M.T.D.

doi:10.1016/j.ijid.2021.12.143

Cited by 3 publications

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A study conducted in Poland found that only 3.5% of those who received the Oxford/AstraZeneca vaccine, and 2.5% of those who received the Pfizer-BioNTech vaccine, experienced no side effects (19). A study evaluating adverse reactions in healthcare workers who received the Oxford/AstraZeneca vaccine in Sri Lanka found that at least one adverse reaction was observed in 87.4% of participants (20). This rate is over 90% in studies in Korea (21), over 80% in Iraq and Jordan (22), and over 70% in Ethiopia (23).…”

Section: Discussionmentioning

confidence: 99%

“…Vaccines may require medical support in patients depending on their side effects (31,32). A review of the literature shows that 0.13% of healthcare workers in Sri Lanka who received the Oxford/AstraZeneca vaccine required hospitalization, while 22.4% required 24-48 hours of rest, and nearly 70% continued to work (20). In a study by Park et al, 9.4% of patients received intravenous treatment due to the first dose of Oxford/AstraZeneca, and 5.3% of patients with Pfizer-BioNTech (25).…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Kuzeybatı Suriye'de COVID-19 aşısı ile ilk aşılanan sağlık çalışanlarının değerlendirilmesi: Acil servislerde aşı yan etkisi gözlemleri

Karaca

ÇELİK

2022

Genel Tıp Dergisi

View full text Add to dashboard Cite

Aim In this study, we investigated the adverse effects of the COVID-19 vaccine administered to health workers in northwestern Syria. Materials and Methods The study retrospectively analyzed data from 260 health care workers who received the first dose of COVID-19 vaccine between May 1, 2021, and June 30, 2021, in the northwestern Syria region by searching the Syrian Immunization Group database (SIG) and patient records from hospital or health center emergency departments. Results The mean age of health care personnel was 35.86∓8.03 years, and 9.6% were women. Of those who participated in the study, 5.8% had comorbid diseases. 109 (42.1%) were vaccinated in hospital emergency departments and 151 (57.9%) in health center emergency departments. It was found that 63.5% (n=165) of those vaccinated experienced adverse reactions to the Oxford/AstraZeneca vaccine. The most common adverse reactions to the vaccine were fever in 128 individuals (49%), fatigue in 89 individuals (55.6%), headache in 54 individuals (20.8%), weakness in 53 individuals (20.4%), joint pain in 50 individuals (19.2%), injection site pain in 47 individuals (18.1%), and muscle pain in 33 individuals (12.7%). The side effects noted were classified as severe, moderate, and mild. Of these, fever 15.4% (n=40), fatigue 11.9% (n=31), and headache 9.6% (n=25) were the most common severe side effects. It was found that 14 (5.4%) individuals required hospitalization and medical treatment due to adverse reactions to the vaccine. When evaluating the side effects observed in hospitalized patients, the most common side effects were fever, chills, muscle pain, joint pain, fatigue, and weakness. Conclusion It was concluded that the Oxford/AstraZeneca vaccine administered to health care workers in northwestern Syria had no fatal side effects and that fewer side effects were generally observed in this study compared with the literature. Research on side effects through independent studies will help address global and regional concerns about vaccines.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Kuzeybatı Suriye'de COVID-19 aşısı ile ilk aşılanan sağlık çalışanlarının değerlendirilmesi: Acil servislerde aşı yan etkisi gözlemleri

Karaca

ÇELİK

2022

Genel Tıp Dergisi

View full text Add to dashboard Cite

show abstract

“… 2 A multicentre study in Sri Lanka failed to identify any significant adverse events following AZD1222 (ChAdOx1) first dose in Sri Lanka. 3 However, we present our experience with a case series identifying serious thrombotic and autoimmune complications following different types of COVID-19 vaccination in Sri Lanka.…”

mentioning

confidence: 99%

Thrombotic and immunological phenomena following COVID-19 vaccination: experience from a case series

Dandeniya

Premathilake

2023

RMD Open

View full text Add to dashboard Cite

Panic in the Pandemic: Determinants of Vaccine Hesitancy and the Dilemma of Public Health Information Sharing during the COVID-19 Pandemic in Sri Lanka

Kamalrathne,

Jayasekara,

Amaratunga

et al. 2024

IJERPH

View full text Add to dashboard Cite

Vaccine hesitancy, a pressing global challenge in vaccination programs, was significantly amplified during the COVID-19 pandemic. The proliferation of misinformation, including false claims and rumours, and the influence of anti-vaccine movements fuelled hesitancy. This study aims to explore the socio-economic determinants that influenced vaccine hesitancy and the impact of public health information sharing in Sri Lanka during the pandemic. The study employed a comprehensive mixed-method approach for data collection, administrating a household survey (n = 3330) and 206 semi-structured interviews. The survey results indicated that 37.8% (n = 3113) of respondents delayed or rejected vaccines for various reasons, the leading cause being the fear of side effects of the vaccine. Although fear of side effects was the prime reason for rejection (n = 1176, 46.29%), respondents demonstrated an extremely poor understanding of the potential side effects of vaccines, which was 55.39% (n = 3113). Notably, 84.60% (n = 3113) were unaware of the vaccine development process. Multivariate logistic regression analysis showed that middle-income people (AOR—0.42) and females (0.65) were less likely not to make decisions based on scientific information compared to underprivileged people and males. The survey also revealed that strong belief in the use of traditional medicines and remedies and religious beliefs (n = 1176, 3.95%) were among the main reasons for hesitancy. The findings illustrate that misinformation, lack of health knowledge, and lack of understanding to seek scientific information have fuelled vaccine hesitancy in Sri Lanka.

show abstract

Prevalence of Covishield COVID-19 Vaccine (ChAdOx1 nCoV-19) Adverse Effects among Health Care Workers in Sri Lanka

Cited by 3 publications

References 0 publications

Kuzeybatı Suriye'de COVID-19 aşısı ile ilk aşılanan sağlık çalışanlarının değerlendirilmesi: Acil servislerde aşı yan etkisi gözlemleri

Kuzeybatı Suriye'de COVID-19 aşısı ile ilk aşılanan sağlık çalışanlarının değerlendirilmesi: Acil servislerde aşı yan etkisi gözlemleri

Thrombotic and immunological phenomena following COVID-19 vaccination: experience from a case series

Panic in the Pandemic: Determinants of Vaccine Hesitancy and the Dilemma of Public Health Information Sharing during the COVID-19 Pandemic in Sri Lanka

Contact Info

Product

Resources

About